Showing 5571-5580 of 9401 results for "".
- Europe Grants DefenAge Skincare Master Patenthttps://practicaldermatology.com/news/europe-grants-defenage-skincare-master-patent/2460132/DefenAge Skincare now has a master patent from the European Patent Office that covers DefenAge’s core technology. The patent protects the exclusive rights of DefenAge to use the spectrum of immune peptides called defensins in topical cosmetic formulations in a specific range of co
- Dr. Jennifer Soung Named New Psoriasis Editorhttps://practicaldermatology.com/news/dr-jennifer-soung-named-new-psoriasis-editor/2460129/Practical Dermatology magazine is pleased to announce that Jennifer Soung, MD is the new psoriasis editor. Dr. Soung, a dermatologist at Southern California Dermatology in Santa Ana, CA, will replace Jerry Bagel, MD. Her first feature article is slated to in the November 2
- Study Shows StrataGraft-treated Deep Partial-thickness Burns Did Not Require Surgical Harvest of Healthy Skinhttps://practicaldermatology.com/news/study-shows-stratagraft-treated-deep-partial-thickness-burns-did-not-require-surgical-harvest-of-healthy-skin/2460127/Mallinckrodt plc shared results of its Phase 1b clinical trial of StrataGraft, an investigational regenerative tissue, in Burns, the journal of the International Society for Burn Injuries (ISBI). Study data showed that treatment with a single application of StrataGraft tissue resulted in
- NRS Releases New Free Resource for Rosacea Patientshttps://practicaldermatology.com/news/nrs-releases-new-free-resource-for-rosacea-patients/2460125/The National Rosacea Society new public service booklet, “Recognizing Redness”, is now available. The free booklet includes a redness register to allow patients to gauge relative redness
- Soliton Treats First Patients in Cellulite Trialhttps://practicaldermatology.com/news/soliton-treats-first-patients-in-cellulite-trial/2460124/The first patients in Soliton’s cellulite trial have been treated, the Company reports. "Patient treatments have now begun at the Chicago site,” says Dr. Chris Capelli, President, CEO and co-founder of Soliton, in a ne
- Straight Up: Paula Abdul Is InMode's New Brand Ambassadorhttps://practicaldermatology.com/news/straight-up-paula-abdul-is-inmodes-new-brand-ambassador/2460122/Paula Abdul is InMode’s new brand ambassador for BodyTite, FaceTite and Morpheus8 technologies. As a lifelong performer, Abdul has always taken care of herself and has the muscles to prove it—however, at age 57, she acknowledg
- PE in Dermatology: NavaDerm Partners with Laser & Skin Surgery Center of NYhttps://practicaldermatology.com/news/pe-in-dermatology-navaderm-partners-with-laser-skin-surgery-center-of-ny/2460119/NavaDerm is partnering with Laser & Skin Surgery Center of New York, Midtown Dermatology and their affiliated entities. Navaderm is a dermatology services organization in the Northeast and a BelHealth Investm
- Complete Wound Healing Seen on Index Lesion of the First Subject in an Ongoing Phase 2 Trial of RGN-137 Dermal Gel for EBhttps://practicaldermatology.com/news/complete-wound-healing-seen-on-index-lesion-of-the-first-subject-in-an-ongoing-phase-2-trial-of-rgn-137-dermal-gel-for-eb/2460118/Lenus Therapeutics, LLC, a US-based joint venture between GtreeBNT and Yuyang DNU in Korea, has confirmed complete wound healing of the index lesion of the first subject enrolled in its ongoing single-masked Phase 2 clinical trial with RGN-137 dermal gel for Epidermolysis Bullosa (EB).
- Foamix Submits NDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosaceahttps://practicaldermatology.com/news/foamix-submits-nda-for-fmx103-for-the-treatment-of-moderate-to-severe-papulopustular-rosacea/2460117/Foamix Pharmaceuticals Ltd. has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for FMX103 for the treatment of moderate-to-severe papulopustular rosacea in patients 18 years of age and older
- Ortho Dermatologics Expands Cash-Pay Prescription Program with Walgreens Agreementhttps://practicaldermatology.com/news/ortho-dermatologics-expands-cash-pay-prescription-program-with-walgreens-agreement/2460115/Ortho Dermatologics’ Cash-Pay Prescription Plan is now available at Walgreen’s stores nationwide. Under the expanded agreement, Walgreens patients will have access to the select dermatology products included in Ortho Dermatologics’ first-of-its-kind cash-pay pres